Campylobacteriosis outbreak associated with consumption of undercooked chicken liver pâté in the East of England, September 2011: identification of a dose-response risk

D S Edwards, L M Milne, K Morrow, P Sheridan, N Q Verlander, R Mulla, J F Richardson, A Pender, M Lilley, M Reacher

Research output: Contribution to journalArticlepeer-review

Abstract

A foodborne outbreak with 49 cases (22 culture positive for Campylobacter sp.) following a wedding party in the East of England was investigated. A retrospective cohort study identified an association between consumption of chicken liver pâté and infection with Campylobacter jejuni/coli. There was a statistically significant association between dose (amount of chicken liver pâté eaten) and the risk of disease ['tasted': odds ratio (OR) 1·5, 95% confidence interval (CI) 0·04-∞; 'partly eaten': OR 8·4, 95% CI 1·4-87·5; 'most or all eaten': OR 36·1, 95% CI 3·3-2119). The local authority found evidence that the preparation of chicken livers breached Food Standards Agency's guidelines. This epidemiological investigation established a clear dose-response relationship between consumption of chicken liver pâté and the risk of infection with Campylobacter. The continuing need to raise public awareness of the risk to human health posed by undercooked chicken liver is evident.
Original languageEnglish
Pages (from-to)352-7
Number of pages6
JournalEpidemiology and Infection
Volume142
Issue number2
DOIs
Publication statusE-pub ahead of print - 28 May 2013

Keywords

  • Adult
  • Animals
  • Campylobacter
  • Campylobacter Infections/epidemiology
  • Chickens/microbiology
  • Disease Outbreaks/statistics & numerical data
  • England/epidemiology
  • Female
  • Foodborne Diseases/epidemiology
  • Gastroenteritis/epidemiology
  • Humans
  • Liver
  • Male
  • Meat/adverse effects
  • Middle Aged

Fingerprint

Dive into the research topics of 'Campylobacteriosis outbreak associated with consumption of undercooked chicken liver pâté in the East of England, September 2011: identification of a dose-response risk'. Together they form a unique fingerprint.

Cite this